A Transcriptomic Map of Murine and Human Alopecia Areata

May 2020 in “ JCI Insight ”

Nicholas Borcherding, Sydney Crotts, Luana dos Santos Ortolan, Nicholas Henderson, Nicholas L. Bormann, Ali Jabbari

alopecia areata autoimmune condition single-cell sequencing immune cell expression profiles CD4+ T cells CD8+ T cells clonal expansions transcriptional states pathogenesis predictive models therapeutic intervention AA immune system T cells

TLDR Alopecia areata involves specific immune cells, offering potential treatment targets.

The study provided a detailed transcriptomic map of immune cells in murine and human alopecia areata (AA) by analyzing 10,505 immune cells, identifying 15 immune cell clusters with distinct gene expression profiles between AA and unaffected samples. It revealed increased proinflammatory signatures in antigen-presenting cells (APCs) and T cells, with APCs polarized towards proinflammatory CD11b+ dendritic cells and significant increases in angiogenic, CD40, IFN-γ, JAK/STAT, and hypoxic signaling. T cell analysis showed increased cytotoxic and proinflammatory activity, with greater clonotypic sharing among T cells in AA. The study also demonstrated that murine AA T cells had a greater shared repertoire and sustained CD4 activation, while human AA gene signatures for CD4+ and CD8+ T cells showed high discrimination performance. Key genes associated with AA were identified, providing insights into the disease's pathogenesis.

View this study on insight.jci.org →

Discuss this study in the Community →

Research cited in this study

14 / 14 results

Alopecia Areata Patients Show Deficiency of FOXP3+CD39+ T Regulatory Cells and Clonotypic Restriction of Treg TCRβ-Chain, Highlighting the Immunopathological Aspect of the Disease

research Alopecia Areata Patients Show Deficiency of FOXP3+CD39+ T Regulatory Cells and Clonotypic Restriction of Treg TCRβ-Chain, Highlighting the Immunopathological Aspect of the Disease

30 citations , July 2019 in “PloS one”

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

research Regulatory T-Cells in Alopecia Areata

21 citations , April 2019 in “Journal of cutaneous pathology”

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

research High-Throughput T Cell Receptor Sequencing Identifies Clonally Expanded CD8+ T Cell Populations in Alopecia Areata

46 citations , October 2018 in “JCI insight”

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

research An Integrated Model of Alopecia Areata Biomarkers Highlights Both TH1 and TH2 Upregulation

58 citations , July 2018 in “Journal of Allergy and Clinical Immunology”

Alopecia areata severity is linked to increased TH1 and TH2 activity.

An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis

research An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis

130 citations , February 2018 in “Journal of Investigative Dermatology”

Tofacitinib may help treat severe hair loss, but more research is needed.

research Oral Ruxolitinib Induces Hair Regrowth in Patients with Moderate-to-Severe Alopecia Areata

196 citations , September 2016 in “JCI insight”

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

research Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate in Patients with Alopecia Areata

222 citations , September 2016 in “JCI insight”

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

research Biomarkers of Alopecia Areata Disease Activity and Response to Corticosteroid Treatment

65 citations , December 2015 in “Experimental dermatology”

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

research Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition

701 citations , August 2014 in “Nature medicine”

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

research Genome-Wide Association Study in Alopecia Areata Implicates Both Innate and Adaptive Immunity

717 citations , June 2010 in “Nature”

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

research Alopecia Areata Update

391 citations , January 2010 in “Journal of The American Academy of Dermatology”

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

research Alopecia in the United States: Outpatient Utilization and Common Prescribing Patterns

46 citations , July 2007 in “Journal of the American Academy of Dermatology”

Alopecia areata causes significant emotional distress, including high rates of depression and anxiety.

research Gene Array Profiling and Immunomodulation Studies Define a Cell-Mediated Immune Response Underlying the Pathogenesis of Alopecia Areata in a Mouse Model and Humans

114 citations , August 2002 in “Journal of Investigative Dermatology”

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

research Experimental Induction of Alopecia Areata-Like Hair Loss in C3H/HeJ Mice Using Full-Thickness Skin Grafts

131 citations , November 1998 in “The journal of investigative dermatology/Journal of investigative dermatology”

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Semantic ratio: 80%